Quantum Biopharma (QNTM) Short-Term Debt issuances (2020 - 2025)
Quantum Biopharma's (QNTM) quarterly Short-Term Debt issuances came in at -$2.5 million in Q1 2025, down 73.64% year-on-year from -$9.4 million in Q1 2024, and down 73.64% quarter-over-quarter from -$1.4 million in Q1 2024.
Quantum Biopharma (QNTM) Short-Term Debt issuances (2020 - 2025) Analysis & Trends
Quantum Biopharma has disclosed Short-Term Debt issuances across 6 years of filings, most recently posting -$2.5 million for Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -33,000.00 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.59 Bn | 54.83 Bn | 3.31 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -2.48 Mn |
| Mar 31, 2025 | -2.48 Mn |
| Mar 31, 2024 | -1.43 Mn |
| Mar 31, 2024 | -1.43 Mn |
| Sep 30, 2023 | -2.04 Mn |
| Sep 30, 2023 | -2.04 Mn |
| Jun 30, 2023 | -3.55 Mn |
| Jun 30, 2023 | -3.55 Mn |
| Mar 31, 2023 | -7.76 Mn |
| Mar 31, 2023 | -7.76 Mn |
| Sep 30, 2022 | 7.87 Mn |
| Sep 30, 2022 | 7.87 Mn |
| Jun 30, 2022 | -3.05 Mn |
| Jun 30, 2022 | -3.05 Mn |
| Mar 31, 2022 | 6.69 Mn |
| Mar 31, 2022 | 6.69 Mn |
| Sep 30, 2021 | -14,988.00 |
| Sep 30, 2021 | -14,988.00 |
| Jun 30, 2021 | -14,989.00 |
| Jun 30, 2021 | -14,989.00 |